SCHEMBL18300074

SCHEMBL18300074

COCOc1cc(OCOC)c(C(=O)/C=C/c2ccc(OCOC)c(OCOC)c2)c(OCOC)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.53
MAPT P10636 7/20 0.53
CYP3A4 P08684 4/20 0.50
ALDH1A1 P00352 2/20 0.50
CYP2D6 P10635 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
TSHR P16473 1/20 0.50
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
HDAC5 Q9UQL6 1/20 0.48
KDM4E B2RXH2 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18300075 1.00 ABCG2 (0.53) ABCG2MAPTCYP3A4ALDH1A1CYP2D6
SCHEMBL9578276 0.93 ABCG2 (0.62) ABCG2MAPTCYP3A4ALDH1A1CYP2D6
SCHEMBL30383008 0.93 ABCG2 (0.62) ABCG2MAPTCYP3A4ALDH1A1CYP2D6
SCHEMBL9578271 0.93 ABCG2 (0.62) ABCG2MAPTCYP3A4ALDH1A1CYP2D6
SCHEMBL25201064 0.88 ABCG2 (0.69) ABCG2MAPTCYP3A4ALDH1A1CYP2D6
SCHEMBL31088178 0.88 ABCG2 (0.69) ABCG2MAPTCYP3A4ALDH1A1CYP2D6
SCHEMBL18957696 0.87 ABCG2 (0.57) ABCG2MAPTCYP3A4ALDH1A1CYP2D6
SCHEMBL9578109 0.86 MAPT (0.63) ABCG2MAPTCYP3A4ALDH1A1CYP2D6
SCHEMBL26113525 0.86 ABCG2 (0.67) ABCG2MAPTCYP3A4ALDH1A1CYP2D6
SCHEMBL9578108 0.86 MAPT (0.63) ABCG2MAPTCYP3A4ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9611255-B2 Process for total synthesis of flavonoid compounds and isomers thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2017-04-04 US claimed
US-20160362401-A1 PROCESS FOR TOTAL SYNTHESIS OF FLAVONOID COMPOUNDS AND ISOMERS THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-12-15 US claimed
US-9611255-B2 Process for total synthesis of flavonoid compounds and isomers thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2017-04-04 US disclosed
US-9611255-B2 Process for total synthesis of flavonoid compounds and isomers thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2017-04-04 US disclosed
US-20160362401-A1 PROCESS FOR TOTAL SYNTHESIS OF FLAVONOID COMPOUNDS AND ISOMERS THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-12-15 US disclosed
US-20160362401-A1 PROCESS FOR TOTAL SYNTHESIS OF FLAVONOID COMPOUNDS AND ISOMERS THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160362401-A1 PROCESS FOR TOTAL SYNTHESIS OF FLAVONOID COMPOUNDS AND ISOMERS THEREOF UGT1A3, F3, UGGT1 ABCG2 773/4885MAPT 1927/4885CYP3A4 306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.